Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

New phase III study of Adcetris begins

May 8, 2012

NRC discloses new single-domain monoclonal antibodies

May 4, 2012

Merck Sharp & Dohme patents novel HER3-specific antibodies

May 4, 2012

New biologicals with anticancer potential discovered in Belgium

May 4, 2012

Genentech ADC shows potential in prostate cancer models

May 4, 2012

Altor BioScience product to enter clinical testing for melanoma

May 3, 2012

BioAnalytica discloses novel HSP 90-targeting antibodies

May 3, 2012

Novel candidate cancer immunotherapies presented by Oxford BioTherapeutics

May 3, 2012

Amgen gives update on Xgeva sBLA

April 27, 2012

GlaxoSmithKline files application in Japan for ofatumumab

April 27, 2012

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...